Teva Pharmaceutical Industries Ltd 10-K for FY2024
Teva Pharmaceutical Industries Ltd (TEVA)
10-K
2025-02-05
For: 2024-12-31
View Original
Added on
April 03, 2026
About this 10-K
Teva Pharmaceutical Industries Ltd filed this 10-K on February 5, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $16.54B
- up 4.4% from $15.85B a year earlier
- Net loss
- $1.64B
- compared with a net loss of $559M a year earlier
- Diluted EPS
- -$1.45
- compared with -$0.50 a year earlier